🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Imjudo & Imfinzi PMS

Recruitingn/aAges any - anyAllAstraZeneca
NCT06544629 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Based on the re-review of new drugs article, Korean pharmaceutical act, the objectives of this study are to assess safety and effectiveness of the study drugs(Imjudo \& Imfinzi) in a real world setting in patients who treated according to the approved indications in Korea.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria: 1. Patients eligible for the study drugs according to the approved label in Korea 2. Provision of signed and dated written informed consent by the patient or legally acceptable representative Exclusion criteria: 1. Other off-label indications according to the approved label in South Korea 2. Current participation in any interventional trial
💊

What it tests

  • Not listed
📍

Where

6 sites
Research Site
Busan, South Korea
Research Site
Goyang, South Korea
Research Site
Seongnam, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Suwon, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy